Open research questions in Respiratory viral infections research
64 unresolved questions extracted from the limitations and future-work sections of 494 Respiratory viral infections research papers in our library. Each links back to the study that raised it.
What the literature leaves open
Abstract Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract infections in infants, yet effective therapeutics are lacking.
Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening · 2026 · DOIOver the next year, focused attention is warranted regarding the durability of vaccine-elicited immunity and the future potential for direct and indirect reduction of illness burden in all adults over 60.
By leveraging well-established GBD methods, this analysis provides internally consistent and comparable estimates of viral LRTD burden, even in regions with limited data availability.
Global Viral Lower Respiratory Disease Episodes, Hospitalisations, and Clinical Outcomes by Aetiology, 2010–2021 · 2026 · DOIBackground Early-life respiratory syncytial virus (RSV) infection is associated with childhood recurrent wheeze or asthma (RW/A), but causality and shared genetic liability remain unclear.
Infant respiratory syncytial virus and childhood asthma: a nationwide phenotyping, sibling-controlled, and genome-wide association study · 2026 · DOIGiven the high incidence of fungal infections in viral ARDS, the role of preemptive antifungal therapy remains uncertain and warrants further investigation.
https://doi.org/10.33619/2414-2948/116/25 Принята к публикации Поступила в редакцию 06.05.2026 г. 16.05.2026 г. ________________________________________________________________________________ Ссылка для цитирования: Valizada S., Ahmadov A., Ismayilzada N. Incidence of Influenza and Acute upper Respiratory Tract Infections in Azerbaijan (2000–2024) // Бюллетень науки и практики. 2026. Т. 12. №7. С. 222-228. https://doi.org/10.33619/2414-2948/128/26 Cite as (APA): Valizada, S., Ahmadov, A., & Ismayilzada, N. (2026). Incidence of Influenza and Acute upper Respiratory Tract Infections in Azerbaijan (2000–2024). Bulletin of Science and Practice, 12(7), 222- 228.
Incidence of Influenza and Acute upper Respiratory Tract Infections in Azerbaijan (2000–2024) · 2026 · DOIFuture studies are warranted to evaluate how physician recommendation behavior evolves as RSV vaccination strategies and national implementation frameworks are more clearly defined.
Physicians’ Attitudes and Early Uptake Tendencies Toward the Newly Introduced Adult RSV Vaccine in Türkiye: A Nationwide Survey Study · 2026 · DOIDatasets for LRT and oral specimens were sparser than for nasal, and this contributed to greater variability, underscoring the need for further diagnostic accuracy studies on alternatives to NP sampling.
One size fits all: A systematic review of the sample types used for the diagnostics of respiratory viruses in children · 2026 · DOIThe RSV fusion (F) protein is central to viral entry and the primary target for neutralizing antibodies, yet little is known about its global evolutionary dynamics and drug-resistance associated changes.
Phylodynamics and molecular epidemiology of the respiratory syncytial virus fusion protein in China · 2026 · DOIRecent microbiome studies have shown that Haemophilus influenzae is frequently co-detected in severe RSV cases and ranks among the bacteria most closely correlated with disease severity; however, its causal role and underlying mechanisms remain unclear.
Live nontypeable Haemophilus influenzae exacerbates respiratory syncytial virus-associated lower airway inflammation · 2026 · DOIThe mechanisms underlying the differential changes ARTICLE IN PRESS ARTICLE IN PRESS ACCEPTED MANUSCRIPT ARTICLE IN PRESS between the HMPV- and RSV-infected children observed in our study remain to be elucidated. At last, the underlying immunological mechanisms of potential viral interference among viruses were also not explored. The mechanisms underlying this viral interference warrant further investigation in future studies. Additionally, COVID-19-postive pediatric cases were excluded from this study, so the influence of COVID-19 on HMPV and RSV infections could not be evaluated directly.
Comparison of human metapneumovirus and respiratory syncytial virus in children with acute lower respiratory infections in Wenzhou, China from 2021 to 2022: a retrospective study · 2026 · DOIThe study used real-world data from before and after the COVID-19 pandemic without year or seasonal stratification, potentially leaving confounding factors from seasonality or pandemic disruptions not fully addressed.
Stratify severe risk in children with respiratory syncytial virus pneumonia—A retrospective study based on machine learning and SHAP interpretation · 2026 · DOIThe study intends to further explore the potential clinical relevance and underlying mechanisms of diarrhea's correlation with severe RSV pneumonia in future investigations.
Stratify severe risk in children with respiratory syncytial virus pneumonia—A retrospective study based on machine learning and SHAP interpretation · 2026 · DOIBaseline RSV antibody levels varied widely; consistent with reports that maternal antibodies are transferred late in the third trimester, preterm infants had lower baseline RSV antibody levels than full-term infants.
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants · 2023 · DOIStudies were excluded if case definition was not clearly defined or not consistently applied, RSV infection was not laboratory confirmed or based on serology alone, or if the report included fewer than 50 cases of acute lower respiratory infection.
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis · 2022 · DOIHowever, estimates of the RSV hospitalization burden have varied, and precision has been limited by the use of age strata grouped in blocks of 6 to ≥ 12 months.
Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age · 2013 · DOIIn our study, this altered response was limited to the vaccinated group, although both vaccinated and non- vaccinated groups 6-23 months of age were apparently effectively exposed to RS virus.
AN EPIDEMIOLOGIC STUDY OF ALTERED CLINICAL REACTIVITY TO RESPIRATORY SYNCYTIAL (RS) VIRUS INFECTION IN CHILDREN PREVIOUSLY VACCINATED WITH AN INACTIVATED RS VIRUS VACCINE · 1969 · DOINo data have been published on real-world RSV vaccine effectiveness (VE) beyond the second season after vaccination.
Bivalent RSVpreF effectiveness against RSV-related lower respiratory tract disease hospitalization and ED visits across three RSV Seasons · 2026 · DOIHowever, how these microenvironmental conditions under different relative humidity (RH) levels regulate RSV survival remains unclear.
Intermediate Relative Humidity Preserves Respiratory Syncytial Virus via a Semi-Solid Bioaerosol State · 2026 · DOIAn important limitation is that our study population differs sig- nificantly from the French population for some characteristics, with a higher education level and a high rate of vaccination against per- tussis.
Prevention of RSV bronchiolitis in infants with maternal immunization or monoclonal antibodies for the newborn: What do women choose? · 2026 · DOIFuture studies should include non-RSV pneumonia control groups to enable direct comparative analyses.
Stratify severe risk in children with respiratory syncytial virus pneumonia—A retrospective study based on machine learning and SHAP interpretation · 2026 · DOISeveral known predictors of severe RSV pneumonia were not incorporated into the model, highlighting the need for further research.
Stratify severe risk in children with respiratory syncytial virus pneumonia—A retrospective study based on machine learning and SHAP interpretation · 2026 · DOIA globally implemented unified phylogenetic classification for human respiratory syncytial virus (HRSV) below the subgroup level remains elusive.
Standardized Phylogenetic Classification of Human Respiratory Syncytial Virus Below the Subgroup Level · 2024 · DOIThe influence of these features on transmission patterns of HRV in the community is understudied.
Human rhinovirus spatial-temporal epidemiology in rural coastal Kenya, 2015-2016, observed through outpatient surveillance · 2019 · DOICONCLUSION: Children and carers may benefit from a clear account of the evidence that the clinical course of RTIs in children varies widely and may be longer that expected, and that prediction for individuals is difficult.
Predicting the clinical course of suspected acute viral upper respiratory tract infection in children · 2004 · DOI
Most-cited papers in Respiratory viral infections research
- The Burden of Respiratory Syncytial Virus Infection in Young Children · New England Journal of Medicine · 2009 · 1,946 citations
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis · The Lancet · 2022 · 1,737 citations
- Respiratory Syncytial Virus–Associated Hospitalizations Among Children Less Than 24 Months of Age · PEDIATRICS · 2013 · 575 citations
- Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic — United States, 2020–2021 · MMWR Morbidity and Mortality Weekly Report · 2021 · 522 citations
- Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City · The Journal of Pediatrics · 2020 · 322 citations
- Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 · MMWR Morbidity and Mortality Weekly Report · 2023 · 309 citations
- Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 · MMWR Morbidity and Mortality Weekly Report · 2023 · 295 citations
- Seasonality of Respiratory Syncytial Virus — United States, 2017–2023 · MMWR Morbidity and Mortality Weekly Report · 2023 · 288 citations
- Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 · MMWR Morbidity and Mortality Weekly Report · 2023 · 261 citations
- Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review · The Journal of Pediatrics · 2020 · 240 citations
Most recent work
- Anellovirus-Mediated Interferon Dysregulation Enhances Virus-Induced Lung Injury · American Journal of Respiratory Cell and Molecular Biology · 2026
- Stratify severe risk in children with respiratory syncytial virus pneumonia—A retrospective study based on machine learning and SHAP interpretation · Frontiers in Pediatrics · 2026
- Limited protective immunity to respiratory syncytial virus and pertussis among adults and healthcare workers in South Korea: A seroepidemiologic study · Human Vaccines & Immunotherapeutics · 2026
- Metagenomic surveillance reveals off-season circulation of respiratory viruses during the COVID-19 pandemic in Salvador, Brazil · New Microbes and New Infections · 2026
- Hypoxia inducible factors regulate pneumovirus replication by enhancing innate immune sensing · Proceedings of the National Academy of Sciences · 2026
- Risk factors for progression to bronchitis or pneumonia in hospitalized children with human rhinovirus infection: a retrospective cohort study using machine learning · Frontiers in Pediatrics · 2026
- Optimizing RSV vaccination in U.S. older adults: Cost-effectiveness insights, payer coverage strategies and implementation pathways · World Journal of Biology Pharmacy and Health Sciences · 2026
- Enflonsia (clesrovimab) and the future of RSV lower respiratory tract disease prevention in neonates · Annals of Medicine & Surgery · 2026
- HIV-driven virome dysbiosis unveils distinct virome features and inter-viral correlations in blood and respiratory niches · Communications Biology · 2026
- Prevention of RSV bronchiolitis in infants with maternal immunization or monoclonal antibodies for the newborn: What do women choose? · International Journal of Infectious Diseases · 2026
Find a gap in your own Respiratory viral infections research sub-topic
This page shows what the Respiratory viral infections research literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →